Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
Neuro-Oncology Program, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
David
D
Rigual
Jingxin
J
Qiu
Robert A
RA
Fenstermaker
Andrew J
AJ
Fabiano
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D001856:Bone Marrow Examination; D001929:Brain Edema / Q000209:etiology / Q000473:pathology; D002528:Cerebellar Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D003520:Cyclophosphamide; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin; D017809:Fatal Outcome; D006801:Humans; D000077269:Lenalidomide; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009422:Nervous System Diseases / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D019635:Neurosurgical Procedures; D011241:Prednisone; D000069283:Rituximab; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014750:Vincristine; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery
D000893:Anti-Inflammatory Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D013792:Thalidomide; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D000077269:Lenalidomide; D014740:Vidarabine; C024352:fludarabine; D011241:Prednisone